NCT00199953View on ClinicalTrials.gov

Post-nasal Drainage as an Extraesophageal Manifestation of Reflux

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Postnasal Drainage
Interventions
DRUG

Rabeprazole 20 mg twice a day for 90-day period treatment

Trial Locations (1)

53226

Medical College of Wisconsin, Milwaukee

All Listed Sponsors
collaborator

Ortho-McNeil, Inc.

INDUSTRY

collaborator

Eisai Inc.

INDUSTRY

lead

Medical College of Wisconsin

OTHER

NCT00199953 - Post-nasal Drainage as an Extraesophageal Manifestation of Reflux | Biotech Hunter | Biotech Hunter